MTA1 and non-small cell lung carcinoma: Similarly, treatment with Cur and paclitaxel also sensitizes paclitaxel-resistant NSCLC cells to paclitaxel via epigenetic modification involving the upregulation of the miRNA-30c-mediated decrease of MTA1 expression [90].